Next-Generation Imaging
Next-Generation Imaging
Advertisement
Zachary BessetteNext-Generation Imaging | January 31, 2023
Dr. Deek shares how PSMA imaging used in both the STOMP and ORIOLE trials.
View More
Zachary BessetteNext-Generation Imaging | January 24, 2023
Dr. Ulaner highlights the line(s) of therapy in which novel RLT-PSMA agents are being developed.
Zachary BessetteNext-Generation Imaging | January 24, 2023
Dr. Ulaner explains the data that led to the FDA approval of 177Lu-PSMA-617 and the safety profile of this drug.
Zachary BessetteNext-Generation Imaging | January 24, 2023
Dr. Ulaner details the current application and capabilities of molecular imaging in prostate cancer.
Tomi Jun, MDExpert Interviews | January 5, 2023
Tomi Jun, MD, shares the clinical actionability and utilization of NGS for prostate cancer in a changing treatment landscape.
Zachary BessetteNext-Generation Imaging | December 22, 2022
The Ga-PSMA-11 and Ga-P16-093 PSMA-PET tracers are useful tools for surgical guidance in prostate cancer.
Emily MenendezNext-Generation Imaging | December 8, 2022
iQuest is the first AI-powered platform of its kind to aid in the development of personalized prostate cancer care plans.
Vanessa IraAUA 2022 | May 16, 2022
This use of molecular MRI with targeted agents can enhance tumor margin detection and inform treatment decision-making.
Advertisement
Advertisement
Advertisement